BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27189823)

  • 1. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
    Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
    J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminology for melanocytic skin lesions and the MPATH-Dx classification schema: A survey of dermatopathologists.
    Radick AC; Reisch LM; Shucard HL; Piepkorn MW; Kerr KF; Elder DE; Barnhill RL; Knezevich SR; Oster N; Elmore JG
    J Cutan Pathol; 2021 Jun; 48(6):733-738. PubMed ID: 32935869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.
    Barnhill RL; Elder DE; Piepkorn MW; Knezevich SR; Reisch LM; Eguchi MM; Bastian BC; Blokx W; Bosenberg M; Busam KJ; Carr R; Cochran A; Cook MG; Duncan LM; Elenitsas R; de la Fouchardière A; Gerami P; Johansson I; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Messina J; Mihic-Probst D; Parker DC; Schmidt B; Shea CR; Scolyer RA; Tetzlaff M; Xu X; Yeh I; Zembowicz A; Elmore JG
    JAMA Netw Open; 2023 Jan; 6(1):e2250613. PubMed ID: 36630138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.
    Piepkorn MW; Barnhill RL; Elder DE; Knezevich SR; Carney PA; Reisch LM; Elmore JG
    J Am Acad Dermatol; 2014 Jan; 70(1):131-41. PubMed ID: 24176521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A standardized approach to classifying melanocytic neoplasms? Comments on the MPATH-Dx system.
    Clarke LE; Hosler GA
    J Cutan Pathol; 2021 Jun; 48(6):730-732. PubMed ID: 33617000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a Diagnostic Classification System for Management of Lesions to Exclude Melanoma.
    Katz I; O'Brien B; Clark S; Thompson CT; Schapiro B; Azzi A; Lilleyman A; Boyle T; Espartero LJL; Yamada M; Prow TW
    JAMA Netw Open; 2021 Dec; 4(12):e2134614. PubMed ID: 34889949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis: Long-term effect of a simple educational intervention.
    Reisch LM; Shucard H; Radick AC; Eguchi MM; Elder DE; Barnhill RL; Piepkorn MW; Knezevich SR; Kerr KF; Elmore JG
    JAAD Int; 2023 Jun; 11():211-219. PubMed ID: 37144178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of multiple diagnostic terms in melanocytic skin lesion pathology reports.
    Chang OH; Elder DE; Barnhill RL; Piepkorn MW; Eguchi MM; Knezevich SR; Lee AC; Moreno RJ; Kerr KF; Elmore JG
    J Cutan Pathol; 2022 Feb; 49(2):153-162. PubMed ID: 34487353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing.
    Lott JP; Boudreau DM; Barnhill RL; Weinstock MA; Knopp E; Piepkorn MW; Elder DE; Knezevich SR; Baer A; Tosteson ANA; Elmore JG
    JAMA Dermatol; 2018 Jan; 154(1):24-29. PubMed ID: 29094145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of Digital Pathologic Analysis vs Traditional Microscopy in the Interpretation of Melanocytic Lesions.
    Onega T; Barnhill RL; Piepkorn MW; Longton GM; Elder DE; Weinstock MA; Knezevich SR; Reisch LM; Carney PA; Nelson HD; Radick AC; Elmore JG
    JAMA Dermatol; 2018 Oct; 154(10):1159-1166. PubMed ID: 30140929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.
    Carney PA; Reisch LM; Piepkorn MW; Barnhill RL; Elder DE; Knezevich S; Geller BM; Longton G; Elmore JG
    J Cutan Pathol; 2016 Oct; 43(10):830-7. PubMed ID: 27247109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Second-Opinion Strategies in the Histopathologic Diagnosis of Cutaneous Melanocytic Lesions With Diagnostic Accuracy and Population-Level Costs.
    Tosteson ANA; Tapp S; Titus LJ; Nelson HD; Longton GM; Bronson M; Pepe M; Carney PA; Onega T; Piepkorn MW; Knezevich SR; Barnhill R; Weinstock MA; Elder DE; Elmore JG
    JAMA Dermatol; 2021 Sep; 157(9):1102-1106. PubMed ID: 34076664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?
    Zembowicz A; Scolyer RA
    Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utilization of spitz-related nomenclature in the histological interpretation of cutaneous melanocytic lesions by practicing pathologists: results from the M-Path study.
    Zhao G; Lee KC; Peacock S; Reisch LM; Knezevich SR; Elder DE; Piepkorn MW; Elmore JG; Barnhill RL
    J Cutan Pathol; 2017 Jan; 44(1):5-14. PubMed ID: 27686456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
    Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
    JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of lipid and pigment content in suspicious melanocytic lesions to improve melanoma detection.
    Amara SV; Grbic N; Melson G; Brem CE; Almier N; Bhawan J; Alani RM; Collard M
    Melanoma Res; 2023 Aug; 33(4):283-292. PubMed ID: 37276030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with use of immunohistochemical markers in the histopathological diagnosis of cutaneous melanocytic lesions.
    May CJ; Piepkorn MW; Knezevich SR; Elder DE; Barnhill RL; Lee AC; Flores MJ; Kerr KF; Reisch LM; Elmore JG
    J Cutan Pathol; 2020 Oct; 47(10):896-902. PubMed ID: 32383301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Prior Diagnoses on Dermatopathologists' Interpretations of Melanocytic Lesions: A Randomized Controlled Trial.
    Elmore JG; Eguchi MM; Barnhill RL; Reisch LM; Elder DE; Piepkorn MW; Brunyé TT; Radick AC; Shucard HL; Knezevich SR; Kerr KF
    JAMA Dermatol; 2022 Sep; 158(9):1040-1047. PubMed ID: 35947391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.
    Elmore JG; Barnhill RL; Elder DE; Longton GM; Pepe MS; Reisch LM; Carney PA; Titus LJ; Nelson HD; Onega T; Tosteson ANA; Weinstock MA; Knezevich SR; Piepkorn MW
    BMJ; 2017 Jun; 357():j2813. PubMed ID: 28659278
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
    Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
    JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.